Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PAPP-A2 a new key regulator of growth.

Endokrynologia Polska - 1 Jan 2017

Banaszak-Ziemska Magdalena, Niedziela Marek

Abstract excerpt

Short stature is the main problem that paediatric endocrinologists have to grapple with. Endocrine disorders account for only 5% of patients with short stature, but this is still one of the most common causes of reports to the endocrine clinic and hospitalisation in the endocrine department. A properly functioning growth hormone/insulin-like growth factor (GH/IGF) axis is one of the most important factors in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to IGF1 gene
Share to Growth
Share to Growth Hormone

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Insulin-Like Growth Factor I

Share to Mutation

Source

Identifiers

PMID: 29238946
DOI: 10.5603/EP.a2017.0060

Genes

IGF1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PAPP-A2 a new key regulator of growth.PMID 29238946Read ↗

Pregnancy-Associated Plasma Protein (PAPP)-A2 in Physiology and Disease.Semantic proximity Read ↗

Disorders caused by genetic defects associated with GH-dependent genes: PAPPA2 defects.Semantic proximity Read ↗

Novel Modulators of the Growth Hormone - Insulin-Like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2Semantic proximity Read ↗

Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family.Semantic proximity Read ↗

Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability.Semantic proximity Read ↗

One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiology.Semantic proximity Read ↗

Treatment With Recombinant Human Insulin-Like Growth Factor-1 Improves Growth in Patients With PAPP-A2 DeficiencySemantic proximity Read ↗

Letter to the Editor: History and clinical implications of PAPP-A2 in human growth: When reflecting on idiopathic short stature leads to a specific and new diagnosis: Understanding the concept of "low IGF-I availability".Semantic proximity Read ↗

Biology of pregnancy‐associated plasma protein‐A in relation to prenatal diagnostics: an overviewSemantic proximity Read ↗

Genetic analysis of the PAPP-A2 gene and evaluation of free IGF-1, IGFBP-5, and ALS concentrations in a group of 22 patients with idiopathic short stature.Semantic proximity Read ↗

The Pregnancy-Associated Plasma Protein-A (PAPP-A) StorySemantic proximity Read ↗

Low IGF-I Bioavailability Impairs Growth and Glucose Metabolism in a Mouse Model of Human PAPPA2 p.Ala1033Val MutationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.